Q3 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VMEM | Sell | Violin Memory, Inc. | $86,000 | -80.2% | 118,275 | -75.0% | 1.54% | -84.6% |
| OPGN | Exit | Opgen, Inc. | $0 | – | -98,779 | – | -3.47% | – |
Q2 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GIMO | New | Gigamon Inc. | $3,739,000 | – | 100,000 | – | 86.47% | – |
| VMEM | New | Violin Memory, Inc. | $435,000 | – | 473,093 | – | 10.06% | – |
| OPGN | New | Opgen, Inc. | $150,000 | – | 98,779 | – | 3.47% | – |
| OPGNW | New | Opgen, Inc.*w exp 05/05/202 | $0 | – | 9,183 | – | 0.00% | – |
Q4 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OPGNW | Exit | Opgen, Inc.*w exp 05/05/202 | $0 | – | -9,183 | – | 0.00% | – |
| OPGN | Exit | Opgen, Inc. | $0 | – | -98,779 | – | -0.25% | – |
| VMEM | Exit | Violin Memory, Inc. | $0 | – | -473,093 | – | -0.64% | – |
| TWOU | Exit | 2U, Inc. | $0 | – | -1,293,165 | – | -45.14% | – |
| GIMO | Exit | Gigamon Inc. | $0 | – | -2,774,500 | – | -53.98% | – |
Q3 2015
Q2 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GIMO | New | Gigamon Inc. | $91,530,000 | – | 2,774,500 | – | 52.33% | – |
| TWOU | New | 2U, Inc. | $81,865,000 | – | 2,543,165 | – | 46.80% | – |
| VMEM | New | Violin Memory, Inc. | $1,159,000 | – | 473,093 | – | 0.66% | – |
| OPGN | New | Opgen, Inc. | $368,000 | – | 98,779 | – | 0.21% | – |
| OPGNW | New | Opgen, Inc.*w exp 05/05/202 | $0 | – | 9,183 | – | 0.00% | – |
Q4 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VMEM | Exit | Violin Memory, Inc. | $0 | – | -473,093 | – | -1.46% | – |
| HPTX | Exit | Hyperion Therapeutics, Inc. | $0 | – | -1,570,944 | – | -25.14% | – |
| TWOU | Exit | 2U, Inc. | $0 | – | -3,543,165 | – | -35.04% | – |
| GIMO | Exit | Gigamon Inc. | $0 | – | -5,774,500 | – | -38.36% | – |
Q3 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HPTX | Sell | Hyperion Therapeutics, Inc. | $39,619,000 | -16.2% | 1,570,944 | -13.3% | 25.14% | +16.7% |
Q2 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GIMO | New | Gigamon Inc. | $110,524,000 | – | 5,774,500 | – | 50.36% | – |
| TWOU | New | 2U, Inc. | $59,561,000 | – | 3,543,165 | – | 27.14% | – |
| HPTX | New | Hyperion Therapeutics, Inc. | $47,268,000 | – | 1,811,020 | – | 21.54% | – |
| VMEM | New | Violin Memory, Inc. | $2,096,000 | – | 473,093 | – | 0.96% | – |